Brodifacoum
    Rodenticide Concentrates

    Brodifacoum

    Professional
    Brodifacoum
    Topo domestico Ratto grigio Ratto

    CAS number


    56073-10-0 

    EC number:


    259-980-5

    IUPAC name:

    3-[3-(4’-bromobiphenyl-4-yl)-1,2,3,4-tetrahydro-1-naphthyi]-4-hydroxycoumarin

    CAS name:

    3-[3-(4’-bromo-[1,1’-biphenyi]-
    4-yI)-1,2,3,4-tetrahydro-lnaphthalenyl]-4-hydroxy-2H-1-
    benzopyra n-2-one 

    BENEFITS

    • Anticoagulants, such as BRODIFACOUM, impair the production
      of vitamin K-dependent coagulation factors by blocking the
      enzyme vitamin K 2,3-epoxide reductase, which regenerates
      vitamin K. This results in the production of dysfunctional
      coagulation factors (Prothrombin, VII, IX, X), leading to
      increased vascular permeability, internal hemorrhage, and
      eventually death. BRODIFACOUM’s structural similarity to
      vitamin K is key to its mechanism. Vitamin K serves as an
      effective antidote, but medical advice is essential.
    • BRODIFACOUM is over 100 times more potent than warfarin on
      a molar basis in rats.

    PROPERTIES

    The rodenticidal properties of BRODIFACOUM were described in 1976. It is an anticoagulant that is effective against rats and mice, including warfarin resistant strains. It is used in agriculture and urban rodent control as ready-touse baits of low concentration (usually 0.005% w/w or less). BRODIFACOUM is one of the newer and more potent secondgeneration anticoagulant rodenticides. BRODIFACOUM differs from the first-generation anticoagulants because it is very potent and only requires a single dose to induce death, if sufficient toxicant is ingested. The target organism doesn’t need multiple ingestions to die, once is usually sufficient, thus reducing the quantity of active ingredient useful to control rat or mice population and also reducing the risk of resistance development. BRODIFACOUM is recommended by Rodenticide Resistance Action Committee (RRAC) for resistance management: control of all anticoagulant-resistant strains (RRAC guidelines on Anticoagulant Rodenticide Resistance Management Date of publication: October 2016).

    Composition

     

    - BRODIFACOUM is a 4-hydroxycoumarin anticoagulant.
    - Optimal solubility and stability in glycolic solvents.

    PACKAGING

     

    Concentrates offered with
    glycolic solutions    		 Assay Packing Storage
     stability *

    BRODIFACOUM 3% concentration

    of 30 g/Kg of BRODIFACOUM

    		 standard 30 g/Kg
    (min. 27 g/kg)

    25 Kg Plastic Jars
    200 Kg on request

    retest advised
    after 1 year 

    BRODIFACOUM 2.5 concentration

    of 25 g/Kg of BRODIFACOUM

    		 standard 25 g/Kg
    (min. 23.8 g/kg)

    25 Kg Plastic Jars
    200 Kg on request

    retest advised
    after 1 year  

    BRODIFACOUM 0.5 concentration

    of 5 g/Kg of BRODIFACOUM

    		 standard 25 g/Kg
    (min. 23.8 g/kg)

    25 Kg Plastic Jars
    200 Kg on request

    retest advised
    after 3 years 

    BRODIFACOUM 0.25 concentration

    of 2.5 g/Kg of BRODIFACOUM

    		 standard 2.5 g/Kg
    (min. 2.38 g/kg)

    25 Kg Plastic Jars
    200 Kg on request

    retest advised
    after 3 years